BioPharmaTrend
News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
  • Interviews
  • Business Intelligence
  • Case Studies
Intelligence
  • Business Intelligence
  • Case Studies
  • Lab
  • Membership
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech

Keith Thomas

Senior Director, Decentralised Clinical Trials Solutions at ICON  


Keith directs the strategic planning and operational use of digital health technologies, digital biomarkers, and digital endpoints for clinical trials at ICON. His background gives him unique insight into both the technical aspects underlying digital health technologies, as well as first-hand experience with real world usage. He leverages this experience to devise successful strategies for clients. Prior to joining ICON, Keith held product and program management roles, driving the successful integration, deployment, and utilisation of digital health technologies in remote patient monitoring, virtual care and clinical research applications. Earlier in his career he held positions at medical device and digital health organisations, focusing on the design and development of hardware, firmware, and software for a variety of digital health technologies. Keith holds a Bachelor of Science degree in Computer Engineering.

Contributing Author

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Latest articles from Keith


How Digital Health Technologies are Reshaping Clinical Development

Jan. 29, 2026   
How Digital Health Technologies are Reshaping Clinical Development

Despite rising trial costs and increasingly complex development timelines, one trend is clear: digital health technologies are rapidly moving from pilot programs to core components of global clinical trial strategy. With regulators now actively encouraging patient-centric designs and real-world data, …

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • Business Intelligence
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Lab Access
  • Lab Membership
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.